IP Library Patent Application 15348188
Patent Application
App. No. 15/348,188

TOPICAL ARGININE-SILICATE-INOSITOL FOR WOUND HEALING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/348,188
Abstract

The present invention generally relates to compositions and methods for topical or transdermal delivery, for promoting wound healing, reducing scarring, and/or promoting hair growth. Specifically, the present disclosure is directed to a topical arginine silicate formulation that demonstrates surprising improvement in wound healing time leading to more advantageous recovery and reducing hospital costs. Such formulations may also lessen scarring. The formulations may, for example, be applied to skin or to mucous membranes to facilitate wound healing.

Claims (24)

1 . A method for decreasing wound healing time comprising:

applying a topical composition comprising an effective amount of arginine silicate inositol (“ASP”) to a wound, wherein the amount decreases wound healing time in comparison to not applying the composition.

2 . The method of claim 1 , wherein the amount of ASI is between about 1% and about 10% of the composition by total weight.

3 . The method of claim 1 , wherein the amount of ASI is about 4% of the composition by total weight.

4 . The method of claim 1 , wherein the composition is selected from the group consisting of a gel, a cream, a lotion, an ointment, a salve, a balm, a foam, and combinations thereof.

5 . The method of claim 1 , wherein the composition comprises a bandage or a patch.

6 . A method for decreasing wound scarring comprising:

applying a topical composition comprising an effective amount of arginine silicate inositol (“ASP”) to a wound, wherein the amount decreases scarring from the wound in comparison to not applying the composition.

7 . The method of claim 6 , wherein the amount of ASI is between about 1% and about 10% of the composition by total weight.

8 . The method of claim 6 , wherein the amount of ASI is about 4% of the composition by total weight.

9 . The method of claim 6 , wherein the composition is selected from the group consisting of a gel, a cream, a lotion, an ointment, a salve, a balm, a foam, and combinations thereof.

10 . The method of claim 6 , wherein the composition comprises a bandage or a patch.

11 . A method for promoting hair growth comprising:

applying a topical composition comprising an effective amount of arginine silicate inositol (“ASP”) to a treatment area on a mammalian subject, wherein the amount promotes hair growth in the treatment area in comparison to non-treatment areas.

12 . The method of claim 11 , wherein the amount of ASI is between about 1% and about 10% of the composition by total weight.

13 . The method of claim 12 , wherein the amount of ASI is about 4% of the composition by total weight.

14 . The method of claim 11 , wherein the composition is selected from the group consisting of a gel, a cream, a lotion, an ointment, a salve, a balm, a foam, and combinations thereof.

15 . The method of claim 11 , wherein the composition comprises a bandage or a patch.

16 . The method of claim 15 , wherein the composition is selected from the group consisting of a shampoo, a conditioner, a leave-in conditioner, a mousse, a pomade, and a hair spray.

17 . A method for reducing inflammation comprising:

applying a topical composition comprising an effective amount of arginine silicate inositol (“ASP”) to a treatment area on a mammalian subject, wherein amount reduces inflammation in the treatment area in comparison to non-treatment areas.

18 . The method of claim 17 , wherein the amount reduces expression levels of a protein selected from the group consisting of NFκB, TGF-β, TNF- 60 , and IL-1β.

19 . The method of claim 17 , wherein the amount of ASI is between about 1% and about 10% of the composition by total weight.

20 . A topical composition comprising between about 1% and about 10% ASI by total weight and at least one pharmaceutically acceptable excipient.

Assignments (2)
SECURITY INTEREST Recorded Nov 9, 2021
From: NUTRITION 21, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 058060/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2021
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 056933/0653 →